BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 32154731)

  • 1. Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
    Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S;
    Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
    Trinder M; Cermakova L; Ruel I; Baass A; Paquette M; Wang J; Kennedy BA; Hegele RA; Genest J; Brunham LR
    Arterioscler Thromb Vasc Biol; 2024 Jul; 44(7):1683-1693. PubMed ID: 38779854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
    Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
    Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia.
    Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA
    J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population-Ascertained Hyperlipidemias.
    Rämö JT; Ripatti P; Tabassum R; Söderlund S; Matikainen N; Gerl MJ; Klose C; Surma MA; Stitziel NO; Havulinna AS; Pirinen M; Salomaa V; Freimer NB; Jauhiainen M; Palotie A; Taskinen MR; Simons K; Ripatti S
    J Am Heart Assoc; 2019 Jul; 8(13):e012415. PubMed ID: 31256696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
    Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
    JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.
    Wünnemann F; Sin Lo K; Langford-Avelar A; Busseuil D; Dubé MP; Tardif JC; Lettre G
    Circ Genom Precis Med; 2019 Jun; 12(6):e002481. PubMed ID: 31184202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.
    Hopkins PN; Nanjee MN; Wu LL; McGinty MG; Brinton EA; Hunt SC; Anderson JL
    Atherosclerosis; 2009 Dec; 207(2):559-66. PubMed ID: 19524242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease.
    Trinder M; Francis GA; Brunham LR
    JAMA Cardiol; 2020 Apr; 5(4):390-399. PubMed ID: 32049305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic Risk Score for Low-Density Lipoprotein Cholesterol Is Associated With Risk of Ischemic Heart Disease and Enriches for Individuals With Familial Hypercholesterolemia.
    Wu H; Forgetta V; Zhou S; Bhatnagar SR; Paré G; Richards JB
    Circ Genom Precis Med; 2021 Feb; 14(1):e003106. PubMed ID: 33440130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
    Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE
    Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of coronary artery disease clinical risk factors by coronary artery disease polygenic risk score.
    Truong B; Ruan Y; Haidermota S; Patel A; Surakka I; Hornsby W; Koyama S; Lee SH; Natarajan P
    Med; 2024 May; 5(5):459-468.e3. PubMed ID: 38642556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease.
    Berry ASF; Jones LK; Sijbrands EJ; Gidding SS; Oetjens MT
    Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):2058-2067. PubMed ID: 37589137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically Elevated LDL Associates with Lower Risk of Intracerebral Hemorrhage.
    Falcone GJ; Kirsch E; Acosta JN; Noche RB; Leasure A; Marini S; Chung J; Selim M; Meschia JF; Brown DL; Worrall BB; Tirschwell DL; Jagiella JM; Schmidt H; Jimenez-Conde J; Fernandez-Cadenas I; Lindgren A; Slowik A; Gill D; Holmes M; Phuah CL; Petersen NH; Matouk Md CN; Gunel M; Sansing L; Bennett D; Chen Z; Sun LL; Clarke R; Walters RG; Gill TM; Biffi A; Kathiresan S; Langefeld CD; Woo D; Rosand J; Sheth KN; Anderson CD;
    Ann Neurol; 2020 Jul; 88(1):56-66. PubMed ID: 32277781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.
    Aragam KG; Dobbyn A; Judy R; Chaffin M; Chaudhary K; Hindy G; Cagan A; Finneran P; Weng LC; Loos RJF; Nadkarni G; Cho JH; Kember RL; Baras A; Reid J; Overton J; Philippakis A; Ellinor PT; Weiss ST; Rader DJ; Lubitz SA; Smoller JW; Karlson EW; Khera AV; Kathiresan S; Do R; Damrauer SM; Natarajan P
    J Am Coll Cardiol; 2020 Jun; 75(22):2769-2780. PubMed ID: 32498804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic risk scores for coronary artery disease and subsequent event risk amongst established cases.
    Howe LJ; Dudbridge F; Schmidt AF; Finan C; Denaxas S; Asselbergs FW; Hingorani AD; Patel RS
    Hum Mol Genet; 2020 May; 29(8):1388-1395. PubMed ID: 32219344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.
    Agbaedeng TA; Noubiap JJ; Mofo Mato EP; Chew DP; Figtree GA; Said MA; van der Harst P
    Atherosclerosis; 2021 Sep; 333():48-55. PubMed ID: 34425527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
    Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
    Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance.
    Trinder M; Brunham LR
    Curr Opin Lipidol; 2021 Apr; 32(2):103-111. PubMed ID: 33395106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.
    Lu X; Liu Z; Cui Q; Liu F; Li J; Niu X; Shen C; Hu D; Huang K; Chen J; Xing X; Zhao Y; Lu F; Liu X; Cao J; Chen S; Ma H; Yu L; Wu X; Wu X; Li Y; Zhang H; Mo X; Zhao L; Huang J; Wang L; Wen W; Shu XO; Takeuchi F; Koh WP; Tai ES; Cheng CY; Wong TY; Chang X; Chan MY; Gao W; Zheng H; Chen K; Chen J; He J; Tang CS; Lam KSL; Tse HF; Cheung CYY; Takahashi A; Kubo M; Kato N; Terao C; Kamatani Y; Sham PC; Heng CK; Hu Z; Chen YE; Wu T; Shen H; Willer CJ; Gu D
    Eur Heart J; 2022 May; 43(18):1702-1711. PubMed ID: 35195259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.